The startup company Gilbert R&D B.V., a subsidiary of Gilbert B.V., announces today that it has received funding for the development of a new generation soft mist inhalers for the precise administration of expensive medicines for people with lung disease. Gilbert has received financing from Brabant Startup Fonds B.V. (“BSF”).
English: Click here for the full text press release.
Dutch: Click here for the full text press release.